Prolotherapy: An effective treatment for low back pain?

  • image.alt
  • With Mayo Clinic neurologist

    Jerry W. Swanson, M.D.

    read biography

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. View sample

Question

Prolotherapy: An effective treatment for low back pain?

Is prolotherapy an effective treatment for chronic low back pain?

Answer

from Jerry W. Swanson, M.D.

Prolotherapy (also called sclerotherapy) involves injecting painful ligaments and tendons with sugar solutions that are intended to stimulate production of connective tissue. The theory is that prolotherapy can strengthen these ligaments and tendons, and reduce pain. Studies of prolotherapy have reported conflicting evidence regarding its effectiveness in treating chronic back pain.

A review of five well-designed studies involving 366 participants concluded that prolotherapy alone was ineffective in treating chronic low back pain. However, when combined with other treatments — such as spinal manipulation and exercise — prolotherapy may improve chronic low back pain.

A typical course of prolotherapy treatment is six to 10 sessions, sometimes with multiple injections at each session. Prolotherapy is known to cause some pain at the injection site, but this is typically mild and temporary. As with any injection, there is a risk of infection, bruising, bleeding or tissue damage.

More research is needed to clarify what role, if any, prolotherapy plays in the treatment of chronic low back pain.

AN01330

April 29, 2008

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger